Axsome Therapeutics Inc (NASDAQ:AXSM)

72.19
Delayed Data
As of Nov 24
 +1.37 / +1.93%
Today’s Change
33.45
Today|||52-Week Range
109.94
-30.16%
Year-to-Date

Today’s Trading

Previous close70.92
Today’s open71.73
Day’s range69.50 - 73.17
Volume251,937
Average volume (3 months)360,706
Market cap$2.7B
Data as of 3:59pm ET, 11/24/2020

Growth & Valuation

Earnings growth (last year)-74.42%
Earnings growth (this year)-37.36%
Earnings growth (next 5 years)-49.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.97

Competitors

----
MCRBSeres Therapeutics I...-3.40-9.98%
BLUEbluebird bio Inc-0.09-0.21%
NKTRNektar Therapeutics+0.16+0.97%
Data as of 4:00pm ET, 11/24/2020

Financials

Next reporting dateMarch 18, 2021
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$0.00
Annual profit (last year)-$68.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
New York, New York

Forecasts